Loring Wolcott & Coolidge Fiduciary Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-94	Closed	-$9K	–	896
2021 Q2	$9K	Buy	+94	New	+$9K	﹤0.01%	651
2021 Q1	–	Sell	-78	Closed	-$11K	–	607
2020 Q4	$11K	Buy	+78	New	+$11K	﹤0.01%	560